Outlook Therapeutics, Inc. (OTLK) shareholders
Close on Nov 17, 2026Market cap $87.79MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Sukhtian Ghiath M. Joint filing with GMS Ventures & Investments (16.40%) | 42,631,142 | 16.40% | 13D (active) amendment | Aug 12, 2026 |
| GMS Ventures & Investments Joint filing with Sukhtian Ghiath M. (22.90%) | 37,580,638 | 22.90% | 13D (active) amendment | May 28, 2026 |
| CVI Investments, Inc. Joint filing with Heights Capital Management, Inc. (9.90%) | 24,713,908 | 9.90% | 13G (passive) | Aug 12, 2026 |
| Empery Asset Management, LP Joint filing with Ryan M. Lane (8.73%) | 21,247,856 | 8.73% | 13G (passive) | Sep 30, 2026 |
| Tenshi Healthcare Pte. Ltd. Joint filing with Arun Kumar Pillai (6.40%) | 16,637,024 | 6.40% | 13D (active) amendment | Jan 25, 2024 |
| Syntone Ventures LLC Joint filing with Syntone LLC (11.40%), Syntone Technologies Group Co., Ltd. (11.40%) | 2,776,867 | 11.40% | 13D (active) amendment | Apr 15, 2024 |
| Great Point Partners, LLC Joint filing with Dr. Jeffrey R. Jay, M.D. (6.37%), Ms. Lillian Nordahl (6.37%) | 2,220,000 | 6.37% | 13G (passive) amendment | Mar 31, 2025 |
| Tang Capital Management, LLC Joint filing with Kevin Tang (5.60%) | 1,900,000 | 5.60% | 13G (passive) amendment | Mar 31, 2025 |
| Sphera Global Healthcare Management LP Joint filing with Sphera Funds Management Ltd. (5.21%), Sphera Global Healthcare GP Ltd. (5.21%) | 1,714,284 | 5.21% | 13G (passive) | Jan 17, 2025 |
| Kevin Tang Joint filing with Tang Capital Management, LLC (6.40%), Tang Capital Partners, LP (5.90%) | 1,682,502 | 6.40% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of OTLK | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 4,376,872 | 1.80% | $6.96M | +2,409,712 | 0.00% |
| Perceptive Advisors LLC | 3,139,216 | 1.29% | $4.99M | New | 0.07% |
| Marshall Wace, Llp | 1,987,578 | 0.82% | $3.16M | New | 0.00% |
| BlackRock, Inc. | 1,668,579 | 0.69% | $2.65M | +1,191,108 | 0.00% |
| Jane Street Group, LLC | 1,425,270 | 0.59% | $2.27M | New | 0.00% |
| Geode Capital Management, LLC | 1,245,868 | 0.51% | $1.98M | +642,262 | 0.00% |
| Susquehanna International Group, Llp | 968,190 | 0.40% | $1.54M | +834,106 | 0.00% |
| Hrt Financial LP | 784,904 | 0.32% | $1.25M | +717,145 | 0.00% |
| Vanguard Fiduciary Trust Co | 661,664 | 0.27% | $1.05M | +485,135 | 0.00% |
| Gilpin Wealth Management, LLC | 555,000 | 0.23% | $882.45K | −45,162 | 0.61% |
| State Street Corp | 539,802 | 0.22% | $858.29K | +376,700 | 0.00% |
| Cantor Fitzgerald, L. P. | 450,000 | 0.18% | $715.50K | New | 0.00% |
| Sanctuary Advisors, LLC | 344,529 | 0.14% | $547.80K | New | 0.00% |
| Raymond James Financial Inc | 332,051 | 0.14% | $527.96K | +305,000 | 0.00% |
| Group One Trading, L.P. | 246,428 | 0.10% | $391.82K | +132,727 | 0.00% |
| Northern Trust Corp | 237,561 | 0.10% | $377.72K | +170,171 | 0.00% |
| Simplex Trading, LLC | 205,013 | 0.08% | $325.97K | +72,347 | 0.00% |
| LPL Financial LLC | 184,942 | 0.08% | $294.06K | +151,315 | 0.00% |
| UBS Group AG | 152,215 | 0.06% | $242.02K | +19,146 | 0.00% |
| Deutsche Bank AG\ | 130,700 | 0.05% | $207.81K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 69 | 20M | 8.4% | 29 / 20 | 7 / 13 | 16M | 6M |
| Q1 2026 | 54 | 11M | 4.4% | 16 / 15 | 6 / 14 | 9M | 3M |
| Q4 2025 | 53 | 7M | 2.8% | 9 / 19 | 8 / 8 | 3M | 0M |
| Q3 2025 | 54 | 4M | 1.7% | 7 / 13 | 25 / 19 | 1M | 3M |
| Q2 2025 | 66 | 6M | 2.5% | 20 / 16 | 18 / 17 | 2M | 3M |
| Q1 2025 | 63 | 7M | 2.9% | 12 / 24 | 14 / 10 | 3M | 1M |
| Q4 2024 | 61 | 5M | 1.9% | 14 / 22 | 12 / 18 | 1M | 5M |
| Q3 2024 | 65 | 8M | 3.3% | 11 / 26 | 10 / 7 | 2M | 1M |
| Q2 2024 | 63 | 8M | 3.3% | 17 / 21 | 11 / 7 | 2M | 1M |
| Q1 2024 | 53 | 7M | 3.0% | 53 / 0 | 0 / 0 | 7M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
10 funds held OTLK in Q2 2026, 88% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of OTLK | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,069,295 | 1.26% | $4.88M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,231,851 | 0.51% | $1.96M | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 382,684 | 0.16% | $279.36K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 57,557 | 0.02% | $42.02K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 52,929 | 0.02% | $38.64K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 46,106 | 0.02% | $73.31K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 29,620 | 0.01% | $47.10K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 7,574 | 0.00% | $5.53K | 0.00% | May 31, 2026 |
| Knights of Columbus U.S. ALL CAP INDEX FUND | 603 | 0.00% | $589 | 0.00% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -7,510 | -0.00% | -$11.94K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert Charles Jahr | Chief Executive Officer, Director | 151,515 | 0.06% | Aug 14, 2026 |
| Lawrence A. Kenyon | Chief Financial Officer, Director | 106,956 | 0.04% | Aug 14, 2026 |
| Kevin Michael Lundquist | Chief Financial Officer | – | – | Sep 2, 2026 |
| Ventures & Investments GMS | Director, 10% owner | 22,092,068 | 9.07% | Aug 14, 2026 |
| Ghiath M. Sukhtian | Director, 10% owner | 46,223,757 | 18.99% | Aug 14, 2026 |
| Faisal Ghiath Sukhtian | Director | 220,972 | 0.09% | Jul 29, 2026 |
| Yezan Munther Haddadin | Director | 66,167 | 0.03% | Jun 3, 2026 |
| Kurt J. Hilzinger | Director | 423,655 | 0.17% | May 27, 2026 |
| Randy H. Thurman | Director | 5,593 | 0.00% | May 27, 2026 |
| Julian S. Gangolli | Director | – | – | Oct 3, 2025 |
| Julia A. Haller | Director | – | – | Oct 3, 2025 |
| Andong Huang | Director | – | – | Oct 3, 2025 |
| Gerd Auffarth | Director | – | – | Oct 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert Charles Jahr Chief Executive Officer, Director | Aug 14, 2026 | Buy | +151,515 | – | – | 151,515 |
| Lawrence A. Kenyon Chief Financial Officer, Director | Aug 14, 2026 | Buy | +101,010 | – | – | 106,956 |
| Ghiath M. Sukhtian Director, 10% owner | Aug 12, 2026 | Buy | +2,525,252 | $0.99 | $2.50M | 24,617,320 |
| Faisal Ghiath Sukhtian Director | Jul 29, 2026 | Buy | +95,398 | $1.05 | $100.17K | 220,972 |
| Yezan Munther Haddadin Director | Jun 2, 2026 | Buy | +29,000 | $0.83 | $24.07K | 66,167 |
| Ventures & Investments GMS Director, 10% owner | May 28, 2026 | Buy | +8,539,709 | $0.59 | $5.04M | 22,092,068 |
| Faisal Ghiath Sukhtian Director | May 27, 2026 | Buy | +122,174 | $0.41 | $50.09K | 125,574 |
| Randy H. Thurman Director | May 26, 2026 | Buy | +5,000 | $0.43 | $2.15K | 5,593 |
| Yezan Munther Haddadin Director | May 26, 2026 | Buy | +34,000 | $0.44 | $14.96K | 37,167 |
| Kurt J. Hilzinger Director | May 26, 2026 | Buy | +400,000 | $0.44 | $176.00K | 423,655 |
| Ghiath M. Sukhtian Director, 10% owner | May 27, 2025 | Award | +4,285,714 | $1.40 | $6.00M | 13,552,359 |
| Ghiath M. Sukhtian Director, 10% owner | Jan 17, 2025 | Option exercise | +3,458,571 | $2.51 | $8.68M | 9,266,645 |
| Lawrence A. Kenyon Chief Financial Officer, Director | Sep 26, 2024 | Buy | +5,000 | $5.69 | $28.45K | 5,946 |
| Ventures LLC Syntone 10% owner | Apr 15, 2024 | Buy | +714,286 | – | – | 1,705,438 |
| Yezan Munther Haddadin Director | Mar 28, 2024 | Buy | +1,881.71 | $11.82 | $22.24K | 5,049 |
| Ghiath M. Sukhtian Director, 10% owner | Mar 18, 2024 | Award | +2,305,714 | – | – | 5,808,074 |
| Jeff Evanson CHIEF COMMERCIAL OFFICER | Mar 7, 2024 | Buy | +62,484 | $0.42 | $26.24K | 808,459 |
| Terry Dagnon Chief Operations Officer | Apr 20, 2023 | Sale | −520,000 | $1.14 | $592.80K | 653,058 |
| Jeff Evanson Chief Commercial Officer | Jan 20, 2023 | Sale | −267,000 | $1.11 | $296.37K | 745,975 |
| Jeff Evanson Chief Commercial Officer | Jan 19, 2023 | Sale | −103,255 | $1.22 | $125.97K | 1,012,975 |
| Jeff Evanson Chief Commercial Officer | Jan 18, 2023 | Sale | −33,738 | $1.25 | $42.17K | 1,116,230 |
| Jeff Evanson Chief Commercial Officer | Jan 17, 2023 | Sale | −27,162 | $1.31 | $35.58K | 1,149,968 |
| Ghiath M. Sukhtian Director, 10% owner | Dec 28, 2022 | Award | +14,230,418 | $0.88 | $12.52M | 70,047,204 |
| Faisal Ghiath Sukhtian Director | Oct 7, 2022 | Buy | +30,000 | $1.29 | $38.70K | 68,000 |
| Yezan Munther Haddadin Director | Oct 7, 2022 | Buy | +3,600 | $1.27 | $4.57K | 63,343 |
| Yezan Munther Haddadin Director | Oct 6, 2022 | Buy | +29,743 | $1.29 | $38.37K | 59,743 |
| Kurt J. Hilzinger Director | Oct 5, 2022 | Buy | +15,662 | $1.23 | $19.26K | 473,117 |
| Kurt J. Hilzinger Director | Oct 4, 2022 | Buy | +95,541 | $1.29 | $123.25K | 457,455 |
| Kurt J. Hilzinger Director | Oct 3, 2022 | Buy | +41,798 | $1.25 | $52.25K | 361,914 |
| Kurt J. Hilzinger Director | Sep 30, 2022 | Buy | +33,199 | $1.26 | $41.83K | 320,116 |
| Kurt J. Hilzinger Director | Sep 29, 2022 | Buy | +13,800 | $1.19 | $16.42K | 286,917 |
| C. Russell Trenary Iii CEO and President, Director | Jun 21, 2022 | Buy | +19,925 | $1.06 | $21.12K | 54,925 |
| Terry Dagnon Chief Operating Officer | Jun 21, 2022 | Buy | +10,000 | $1.05 | $10.50K | 1,173,058 |
| Ghiath M. Sukhtian Director, 10% owner | Apr 21, 2022 | Other | +27,982,529 | – | – | 55,816,786 |
| Pte Ltd. BioLexis 10% owner | Apr 21, 2022 | Other | −27,982,529 | – | – | 22,982,529 |
| Ventures & Investments GMS Director, 10% owner | Apr 21, 2022 | Other | +27,982,529 | – | – | 55,816,786 |
| Kurt J. Hilzinger Director | Mar 1, 2022 | Buy | +27,708 | $1.69 | $46.83K | 273,117 |
| Kurt J. Hilzinger Director | Feb 28, 2022 | Buy | +6,000 | $1.60 | $9.60K | 245,409 |
| Kurt J. Hilzinger Director | Feb 24, 2022 | Buy | +41,160 | $1.46 | $60.09K | 239,409 |
| Kurt J. Hilzinger Director | Feb 23, 2022 | Buy | +79,535 | $1.44 | $114.53K | 198,249 |
| Kurt J. Hilzinger Director | Feb 22, 2022 | Buy | +95,597 | $1.49 | $142.44K | 118,714 |
| Ventures & Investments GMS Director, 10% owner | Feb 1, 2022 | Other | +2,500,000 | $1.25 | $3.13M | 27,982,529 |
| Arun Kumar Pillai Director, 10% owner | Feb 1, 2022 | Other | −2,500,000 | $1.25 | $3.13M | 22,982,529 |
| C. Russell Trenary Iii CEO and President, Director | Dec 6, 2021 | Buy | +25,000 | $1.39 | $34.75K | 35,000 |
| Terry Dagnon Chief Operating Officer | Dec 6, 2021 | Buy | +25,201 | $1.38 | $34.78K | 1,163,058 |
| Jeff Evanson Chief Commercial Officer | Dec 3, 2021 | Buy | +35,200 | $1.34 | $47.17K | 1,177,130 |
| Terry Dagnon Chief Operating Officer | Dec 3, 2021 | Buy | +10,000 | $1.42 | $14.20K | 1,137,857 |
| C. Russell Trenary Iii CEO and President, Director | Dec 2, 2021 | Buy | +10,000 | $1.40 | $14.00K | 10,000 |
| Yezan Munther Haddadin Director | Dec 2, 2021 | Buy | +10,000 | $1.39 | $13.90K | 30,000 |
| Faisal Ghiath Sukhtian Director | Dec 2, 2021 | Buy | +18,000 | $1.40 | $25.20K | 38,000 |
| Ghiath M. Sukhtian Director, 10% owner | Nov 29, 2021 | Buy | +16,000,000 | $1.25 | $20.00M | 27,834,257 |
| Lawrence A. Kenyon CEO, Pres, CFO, Treas & Secy, Director | Apr 20, 2021 | Buy | +10,000 | $1.83 | $18.30K | 18,926 |
| Yezan Munther Haddadin Director | Apr 19, 2021 | Buy | +10,000 | $1.82 | $18.20K | 20,000 |
| Faisal Ghiath Sukhtian Director | Apr 19, 2021 | Buy | +10,000 | $1.82 | $18.20K | 20,000 |
| Jeff Evanson Chief Commercial Officer | Feb 23, 2021 | Sale | −8,554 | $2.09 | $17.88K | 1,141,930 |
| Terry Dagnon Chief Operating Officer | Feb 23, 2021 | Sale | −15,900 | $2.09 | $33.23K | 1,127,857 |
| Terry Dagnon Chief Operating Officer | Feb 12, 2021 | Sale | −63,700 | $2.55 | $162.44K | 1,143,757 |
| Jeff Evanson Chief Commercial Officer | Feb 12, 2021 | Sale | −56,973 | $2.55 | $145.28K | 1,150,484 |
| Ghiath M. Sukhtian Director, 10% owner | Feb 10, 2021 | Award | +1,013,627 | $1.00 | $1.01M | 11,834,257 |
| Ventures LLC Syntone 10% owner | Feb 3, 2021 | Buy | +3,000,000 | $1.00 | $3.00M | 19,823,045 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Outlook Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 165,010 shares on Oct 8, 2026 over the last 90 days.
See a number that looks wrong?